Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chelation therapy in lead nephropathy.

J M Morgan

    Southern Medical Journal
    |August 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Early recognition and energetic treatment of lead nephropathy can stabilize or improve kidney function. Dosage adjustments for ethylenediaminetetraacetic acid (EDTA) are crucial in patients with renal failure due to its creatinine-like excretion.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators.

    International journal of cardiology·2016
    Same author

    "Leadless" pacing of the left ventricle in adult congenital heart disease.

    International journal of cardiology·2016
    Same author

    Leadless pacing: The old with the new.

    International journal of cardiology·2015
    Same author

    Safety and efficacy of multipolar pulmonary vein ablation catheter vs. irrigated radiofrequency ablation for paroxysmal atrial fibrillation: a randomized multicentre trial.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2014
    Same author

    The evaluation of pulmonary vein isolation and wide-area left atrial ablation to treat atrial fibrillation in patients with implanted permanent pacemakers: the Previously Paced Pulmonary Vein Isolation Study.

    Heart (British Cardiac Society)·2010
    Same author

    What is the role for revascularisation in patients being considered for ICD therapy?

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2009
    Same journal

    The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

    Southern medical journal·2026
    Same journal

    α-Gal Syndrome in the South: Why We Need Treatment Trials, Not Just Tick Prevention.

    Southern medical journal·2026
    Same journal

    Association between Main Pancreatic Duct Size, Comorbidities, and Fistula Formation after Whipple Procedure for Pancreatic Cancer.

    Southern medical journal·2026
    Same journal

    Impact of Temperature Variation on Patients with Acute Severe Asthma.

    Southern medical journal·2026
    Same journal

    Assessing the Accuracy and Reliability of ChatGPT-4 to Answer Clinical EHR Messages in Sports Medicine.

    Southern medical journal·2026
    Same journal

    Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Toxicology
    • Internal Medicine

    Background:

    • Lead nephropathy treatment is understudied compared to other lead exposures.
    • Lead exposure can cause significant kidney damage.

    Purpose of the Study:

    • To review available chelating agents for lead nephropathy.
    • To present treatment outcomes in 17 lead nephropathy cases.
    • To emphasize early diagnosis and intervention for lead nephropathy.

    Main Methods:

    • Review of chelating agents used in lead nephropathy.
    • Analysis of treatment results from 17 patient cases.
    • Assessment of renal function before and after treatment.

    Main Results:

    Related Experiment Videos

  • Energetic treatment may stabilize or improve renal function in lead nephropathy.
  • Ethylenediaminetetraacetic acid (EDTA) dosage requires careful adjustment in renal failure.
  • EDTA excretion parallels creatinine, necessitating dose reduction with elevated serum creatinine.

    • Conclusions:

    • Lead nephropathy requires early recognition and aggressive treatment.
    • Chelation therapy can be effective in managing lead nephropathy.
    • Renal function monitoring and dose adjustment of chelating agents like EDTA are critical in patients with impaired kidney function.